These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 31513035)

  • 1. Using buprenorphine to treat patients with opioid use disorder.
    Radi JK; Fogarty KJ; Lagerwey MD
    JAAPA; 2019 Oct; 32(10):30-35. PubMed ID: 31513035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why 24 State and Territorial Health Officials Support Buprenorphine Deregulation.
    Stancliff S; Greene D; Zucker HA
    Am J Public Health; 2019 Dec; 109(12):1678-1679. PubMed ID: 31693402
    [No Abstract]   [Full Text] [Related]  

  • 3. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
    Jones CM; McCance-Katz EF
    Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid use disorder and COVID-19: Implications for policy and practice.
    Mitchell M; Shee K; Champlin K; Essary AC; Evans M
    JAAPA; 2021 Jun; 34(6):1-4. PubMed ID: 34031321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Food and Drug Administration approval of sustained-release buprenorphine for treatment of opioid dependence: realizing its potential.
    Sigmon SC; Bigelow GE
    Addiction; 2017 Mar; 112(3):386-387. PubMed ID: 27561982
    [No Abstract]   [Full Text] [Related]  

  • 6. What Role Should Psychiatrists Have in Responding to the Opioid Epidemic?
    Muvvala SB; Edens EL; Petrakis IL
    JAMA Psychiatry; 2019 Feb; 76(2):107-108. PubMed ID: 30484813
    [No Abstract]   [Full Text] [Related]  

  • 7. Nurse Practitioner and Physician Assistant Waivers to Prescribe Buprenorphine and State Scope of Practice Restrictions.
    Spetz J; Toretsky C; Chapman S; Phoenix B; Tierney M
    JAMA; 2019 Apr; 321(14):1407-1408. PubMed ID: 30964519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine Supply, Access, and Quality: Where We Have Come and the Path Forward.
    Breen CT; Fiellin DA
    J Law Med Ethics; 2018 Jun; 46(2):272-278. PubMed ID: 30147002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rethinking Opioid Dose Tapering, Prescription Opioid Dependence, and Indications for Buprenorphine.
    Chou R; Ballantyne J; Lembke A
    Ann Intern Med; 2019 Sep; 171(6):427-429. PubMed ID: 31450240
    [No Abstract]   [Full Text] [Related]  

  • 10. Geographic and specialty distribution of US physicians trained to treat opioid use disorder.
    Rosenblatt RA; Andrilla CH; Catlin M; Larson EH
    Ann Fam Med; 2015; 13(1):23-6. PubMed ID: 25583888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prescribing of buprenorphine by advanced practice addictions nurses.
    Strobbe S; Hobbins D
    J Addict Nurs; 2012 Feb; 23(1):82-3. PubMed ID: 22468667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Buprenorphine to Treat Opioid Use Disorder.
    Bartholow LAM; Pope J
    J Psychosoc Nurs Ment Health Serv; 2018 Nov; 56(11):9-12. PubMed ID: 30383881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Legal Authority for Emergency Medical Services to Increase Access to Buprenorphine Treatment for Opioid Use Disorder.
    Davis CS; Carr DH; Glenn MJ; Samuels EA
    Ann Emerg Med; 2021 Jul; 78(1):102-108. PubMed ID: 33781607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buprenorphine Dispensing after Elimination of the Waiver Requirement.
    Chua KP; Bicket MC; Bohnert ASB; Conti RM; Lagisetty P; Nguyen TD
    N Engl J Med; 2024 Apr; 390(16):1530-1532. PubMed ID: 38657250
    [No Abstract]   [Full Text] [Related]  

  • 15. In Rural Areas, Buprenorphine Waiver Adoption Since 2017 Driven By Nurse Practitioners And Physician Assistants.
    Barnett ML; Lee D; Frank RG
    Health Aff (Millwood); 2019 Dec; 38(12):2048-2056. PubMed ID: 31794302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIME TO REVISIT UNEVEN POLICY IN THE UNITED STATES FOR MEDICATION FOR OPIOID USE DISORDER DURING COVID-19.
    Pena E; Ahmed S
    Addiction; 2020 Oct; 115(10):1978-1979. PubMed ID: 32447795
    [No Abstract]   [Full Text] [Related]  

  • 17. Perioperative Management and Analgesia for Patients Taking Buprenorphine and Other Forms of Medication-Assisted Treatment for Substance Abuse Disorders.
    Scholzen E; Zeng AM; Schroeder KM
    Adv Anesth; 2019 Dec; 37():65-86. PubMed ID: 31677660
    [No Abstract]   [Full Text] [Related]  

  • 18. Early-Career and Graduating Physicians More Likely to Prescribe Buprenorphine.
    Peterson LE; Morgan ZJ; Eden AR
    J Am Board Fam Med; 2020; 33(1):7-8. PubMed ID: 31907240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine Treatment for Opioid Use Disorder: An Overview.
    Shulman M; Wai JM; Nunes EV
    CNS Drugs; 2019 Jun; 33(6):567-580. PubMed ID: 31062259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medications for management of opioid use disorder.
    Koehl JL; Zimmerman DE; Bridgeman PJ
    Am J Health Syst Pharm; 2019 Jul; 76(15):1097-1103. PubMed ID: 31361869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.